chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site: Pain at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Joint Pain-Severe, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: Coordinator  reached out via email on 2/17 stating the employee had been experiencing numbess and pain in her arm since COVID vaccine shot 2. She will be following up her MD 2/18.
A report has been received from a Physician concerning a 16 year old, female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. It was reported that the patient had received expired FLUMIST Quadrivalent on 09-DEC-2014. The outcome of the event of patient received expired FLUMIST Quadrivalent was unknown. The report was considered to be non-serious.
Seven days after patient received VZV, Comvax, and MMR vaccines, patient developed 20-30 lesions on the abdomen consistent with varicella lesions. Patient did not require hospitalization. She did require a doctor visit and supportive therapy.
Fever of 101.8, body aches, headache. Feeling very flu-lile
Fever above 100 degrees F, body aches, chills, headache, GERD, muscle fatigue, exhaustion
After receiving first dose of Moderna Vaccine a week later I started to experience a mild burning sensation in my heart and dull pain on the right side of the heart. It is not constant but comes and goes at random. I reported this to my cardiac surgeon (when I saw him on January 31, 2022. He has scheduled an Echocardiogram and a Stress Test for me in response to my complaint of the first dose of the Moderna vaccine. He advised me not to receive the second injection until he reviews the results of my upcoming Echocardiogram and Stress tests.
pulmonary embolisms; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "pulmonary embolisms".  Clinical course: covid vaccine almost killed myself, reporter's son and daughter. All 3 of them developed blood clots (pulmonary embolisms) in the same time frame after getting the vaccine. They have all suffered life changing effects and have ongoing medical issues as well as of medical bills. And they were not old and fat and out of shape. In fact, if it hadn't been for being somewhat in shape none of them would have lived through it.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
first dose / January 2020 / has been over a year / have to restart series ?; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details provided were as follows: The age at vaccination is not applicable for this report. Till the time of reporting patient did not received 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter enquired whether patient need to restart the series. No further details provided.
Friday 9/17: 1 hour after getting vaccine I was tired and had a headache  Saturday 9/18: I woke up around 9:30am and my heart felt like it was fluttering, I had pressure on my sternum, and it felt as though there was something pressing on my throat making it hard to breath. The headache was still there and very noticeable. I went about my daily routine, except I was so exhausted that I could hardly stay awake. This continued all day. I noticed that the chest pressure/fluttering was worsened by eating our drinking.  Sunday 9/19: all of the previous day's symptoms continued and I began to be winded after walking from one room to another.  Monday/Tuesday 9/20-21: the headache went away and I wasn't exhausted, but the other symptoms were very present.  Wednesday 9/22: I woke up with the symptoms like U had been, but as soon as I started to move around the pressure turned into the feeling that my heart was going to explode. I went to my local urgent care center. They ran tests and sent me to the hospital to have more tests run. The hospital found I wasn't having a heart attack or had a blood clot. They sent me home to rest. Thursday 9/23-Friday 10/1: The symptoms were still very present in my daily routine, but lessened over time.  10/8/21: I received my 2nd dose
no adverse event. moderna confirmed 216K22A was viable until 2/21/23 despite of beyond use date of 1/22/23.
On 12-31-11 rec'd expired vaccine HIB lot UH160AA exp 11-27-11 consider non-dose spike event. Mother will bring child on 1-7-11 for repeat dose.
Very sore right arm.  Had a good sleep.  6 am took a shower , felt extremely weak and within 10 minutes could not stay standing.  Neck was very  sore.  Felt like I could not hold up my head.  Collapsed on floor.  Got to bed and slept until 3 pm, in 3 hr. increments.    Felt better after 3, and much better the following day.
Shingles; Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. In 2018, plaintiff was inoculated with zoster vaccine live (ZOSTAVAX), (lot# and route unknown) as prescribed and/or administered by a healthcare provider for the long term prevention of shingles and/or zoster-related conditions.Subsequently to Plaintiff's zoster vaccine live (ZOSTAVAX) inoculation, plaintiff was treated at a medical office for shingles. As a direct and proximate result of Plaintiff's use of the zoster vaccine live (ZOSTAVAX), Plaintiff had and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not provided.  The lawyer considered shingles to be related to  zoster vaccine live (ZOSTAVAX).
Pfizer-BioNTech COVID-19 Vaccine EUA -fever: started 7/2 and on/off low grade fever until 7/27 -headache: started 7/2 and lasted for 48 days -nausea: started 7/1 and lasted for 24 hours -chest pain: started 7/2 and lasted for 7 days -fatigue/extreme tiredness: started 7/2 and lasted for 7 days -sore arm at the injection site: started immediately lasted and lasted for 48 hours -ovary pain: started 7/8 and lasted for 6 hours -swollen lymph nodes: not sure when it started but I noticed it on 7/10 in my underarms and chest
Patient's mother called and stated that her daughter's arm had swollen to the size of a baseball around 3pm the day after the vaccinations (11/3/19).  She stated that the pharmacist was having trouble giving the vaccine.  The pharmacist who gave the vaccine states that the patient moved right as she was giving the vaccine so the needle grazed the arm, but did not go in so she proceeded to switch the needle with a new clean needle, then gave the vaccine as she normally would.  The patient's mother said she does not have a fever or any other side effects.  The mother was instructed to call the pediatrician's office and the pediatrician told her she could ice the vaccine site.  They told her if the swelling got worse or did not improve to bring her into the office.  The patient's mother is going to call us after the patient gets home from school to let us know how her daughter is doing.
Infant developed pneumococcal bacteremia, pneumonia and meningitis (2/19/07). Was hospitalized for treatment at hospital. Blood culture was positive for Strep. pneumoniae type 19A. Spinal fluid was culture negative, but positive 109 white cells/me, 83% neutrophils. Infant was treated with IV Ceftriaxone at meningitis doses for 14 days. Repeat blood culture after antibiotics negative. Patient seen in follow up and had recovered. 8/2/07-records received for DOS 2/19-3/7/07-DC DX: Streptococcal pneumonia. Meningitis. Bacteremia. Presented with fever, decreased activity, increased fussiness, congestion, decreased p.o. intake and cough. PE: decreased air movement in right upper and middle lobes with crackles. Tachypnea, desaturations and retractions. Hearing evaluation showed middle ear pathology and conductive hearing loss bilaterally
This medically confirmed spontaneous report (initial receipt 24-Jun-3013) concerns an elderly male patient. Earlier this year, the patient received influenza (batch and manufacturer unspecified) for vaccination. The patient developed a tachycardia and went to the emergency room following vaccination with flu vaccine. The patient had an abnormal EKG (electrocardiogram) in the emergency room. The patient sought medical attention via emergency room visit. The event outcome was recovered.
Approximately 10 minutes after receiving the injection, I started getting extremely dizzy, started sweating profusely, had trouble understanding people talking to me, was nauseous and hot I was put in a wheelchair and taken to another tent where my vitals were taken BP initially was 80/60, but went up to 106/74 after 20 minutes My heart rate was rapid and still is, 1 hour after the dose  I feel very drained
itching; constant at the site had the blisters; This case was reported by a consumer via interactive digital media and described the occurrence of injection site itching in a 73-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced injection site itching and injection site blisters. On an unknown date, the outcome of the injection site itching and injection site blisters were not recovered/not resolved.   It was unknown if the reporter considered the injection site itching and injection site blisters to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was unknown. The patient couldn't remember which prescription he/she got, as it had been 2 years and he/she had a constant at the site had the blisters. The patient stated it wasn't the Covid vaccine, he/she believed it might had been the other vaccine for shingles. The patient enquired, after a year would the itching persist, as it really bothered him/her and would the itching persist after treatment. The patient wanted to know could the itching be a long term affect to the vaccines. The follow-up would not be possible as no contact details were available.
Blister at the injection site; Itchy at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE VESICLES (Blister at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE VESICLES (Blister at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site). At the time of the report, VACCINATION SITE VESICLES (Blister at the injection site) and VACCINATION SITE PRURITUS (Itchy at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment for the events was not provided.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
a sense of confusion the entire day; head felt strange; bones felt weak; booster; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16Nov2021 12:00 (Lot number: FF8839) at the age of 40 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Past drug history included No. Vaccination history included Bnt162b2 (Dose Number: 2, Batch/Lot No: Unknown. upon request), for COVID-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: Unknown. upon request), for Covid-19 immunization. The following information was reported IMMUNISATION (non-serious) with onset 16Nov2021 12:00, outcome unknown; CONFUSIONAL STATE (non-serious) with onset 17Nov2021, outcome recovering; HEADACHE (non-serious) with onset 16Nov2021, outcome recovering; FEELING ABNORMAL (non-serious) with onset 17Nov2021, outcome recovering; BONE DISORDER (non-serious) with onset 17Nov2021, outcome recovering. Therapeutic measures were not taken as a result of confusional state, headache, feeling abnormal, and bone disorder.  The patient did not receive other vaccine in four weeks and other medications in two weeks. She got headache with the booster short on 16Nov2021. On 17Nov2021, she had headache and a sense of confusion the entire day, her head felt strange, her bones felt weak. The patient did not received treatment for the events. The patient was not diagnosed with covid-19 prior vaccination. The patient has not been tested positive for Covid-19, post vaccination. Patient had no known allergies.  Follow-up attempts are completed. No further information is expected.
pt had a previous positive COVID test on 9/1/21; to ED on 10/1/21 after a fall, pt on Eliquis; admitted with acute on chronic hypoxic respiratory failure due to COVID PNA and CHF; on O2; given dexamethasone and bronchodilators; previously treated with remdesivir; still has a positive COVID test; respiratory status stable; DNI but would like other resuscitative measures; imaging consistent heat failure; dc'd to home with home care where he passed away, cause of death is COVID 19.
ACUTE RESPIRATORY FAILURE 4/19/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient had not experienced any 'reactions'/No additional AE reported; Patient's 1st PNEUMOVAX 23 dose on 02/17/2022 was administered a 2nd PNEUMOVAX 23 dose on 04/22/2022; This spontaneous report was received from a healthcare business professional and refers to a patient of unknown age and gender. The patient's medical history, concomitant therapies and concurrent conditions were not provided.  On 17-FEB-2022, the patient was vaccinated with a first dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (dose, strength, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On 22-APR-2022, the patient was vaccinated with a second dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection (dose, strength, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis (extra dose administered). The patient had not experienced any 'reactions' as it was confirmed by the reporter at the time of the report (no adverse event).
8/25/21 Pounding heart, dizziness headache. 8/26/21 Feeling unwell still pounding heartbeat could not lift and use left arm. 8/27/21 left work early 102 fever chills severe headache swollen face. 8/28/2021 Missed work swollen face severe headache chills fever still pounding heart. 8/29 pounding heart fatigue headache. 8/30 Same. 8/31 felt better but still pounding heart rate that lasted until 9/2/2021. Due to the side effect of my pounding heart rate I have cancelled 2nd dosage. The other side effects are manageable but not something as alarming as my heart pounding for 9 days
During the shot it felt like she stuck into to far in my arm. It felt like it hit a bone. I felt the shot being administered. My two doses before this was painless and uneventful. I felt nothing and suffered no side effects including no pain at the injection site. But my booster shot was completely different. Starting the administration, the immediate pain at the injection site, and the continue pain the following day and stiffness in my upper left arm.
PT recvd vax & devel fever & exp myalgia following vax w/Hep B vax; No further details were provided;
BREAKTHROUGH COVID: FULLY VACCINATED WITH BOOSTER. 57-year-old male patient COVID POSITIVE, who is C5-C-7 quadriplegic. He presented with complaints of worsening shortness of breath, chills, cough and hemoptysis x2 episodes. PT hemoptysis was about a quarter-size of dark blood but that he is now expectorating yellow phlegm.  Pt at home with antibiotics ,with his last dose completed yesterday prior to hospitalization.  At home he uses a cough assist, vest, and nebulizer treatments. He is on Trilogy vent at night. He has been afebrile since admission. Recent influenza infection.
Pfizer biontech booster vaccine use for COVID-19 under Emergency Use Authorization (EUA): diagnosed with new onset systolic heart failure
fever, h/a, swollen arm w/redness, tender, bruising, 3in induration;
Pt is a 79F with hx of copd, lung ca, cad, ckd3, presenting to ED for gradually worsening sob. She notes that around the 8th of Feb she noticed increase in sob and cough. She took a course of prednisone and azithromycin prescribed by her pulmonologist but she began feeling worse. Denies any fevers or sick contacts, no travel. Denies any chest pain or pressure. She has O2 at home which she uses prn. This past week she has felt like she needed it constantly and has been using her nebs often which she normally doesn't. Does have slightly increased sputum and wheezing.
Information has been received from a physician concerning a 46 year old Black male who on 5/19/00 was vaccinated with the 1st dose of Hep-B lot 1240H, IM in the deltoid. Three days later or on 5/24/00, the pt developed an itchy rash on his hands and arms. The reporter indicated that the pt works outside. The pt sought medical attention from his physician. On an unspecified date, the pt recovered. It was also reported that on 6/27/00, the pt was vaccinated with the 2nd dose of Hep-B lot 1240M, IM in the deltoid. No reactions were noted. No further information is expected.
skin disorder/area on elbow; Pain in arm; Shoulder pain//pain in shoulder; Back pain/pain in back; Neck pain/pain was coming from neck; COVID-19; COVID-19; This is a solicited report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4240828-00.  A 49-year-old female patient received BNT162b2 (BNT162B2), in Apr2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 48 years intramuscular for covid-19 immunisation; adalimumab (HUMIRA), first regimen from Nov2021 (Batch/Lot number: unknown) to Jan2022 at 40 mg (40 mg (citrate free), 1 in 2 weeks) and second regimen since Jan2022 (ongoing) (Batch/Lot number: unknown) at 40 mg, all subcutaneous for psoriasis. The patient's relevant medical history included: "Plantar Fasciitis", start date: 2020 (unspecified if ongoing), notes: Started 2020; "Non Smoker" (unspecified if ongoing); "Dermatitis" (unspecified if ongoing); "Alcohol/one beer or one glass wine, Occasionally" (unspecified if ongoing). Concomitant medication(s) included: MINOCYCLINE taken for dermatitis. Vaccination history included: Covid-19 vaccine (Intramuscular), administration date: Jan2021, for Covid-19 immunisation; Covid-19 vaccine (Intramuscular), administration date: Mar2021, for Covid-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "recovered" (Jan2022) and all described as "COVID-19"; SKIN DISORDER (non-serious), outcome "unknown", described as "skin disorder/area on elbow"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Pain in arm"; ARTHRALGIA (non-serious), outcome "unknown", described as "Shoulder pain//pain in shoulder"; BACK PAIN (non-serious), outcome "unknown", described as "Back pain/pain in back"; NECK PAIN (non-serious), outcome "unknown", described as "Neck pain/pain was coming from neck". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jan2022) Positive; X-ray: (13Apr2022) Unknown results, notes: Pain was coming from neck; (13Apr2022) Unknown results, notes: Pain was coming from neck. The action taken for adalimumab was dosage not changed.  The reporter's assessment of the causal relationship of "covid-19", "skin disorder/area on elbow", "pain in arm", "shoulder pain//pain in shoulder", "back pain/pain in back" and "neck pain/pain was coming from neck" with the suspect product(s) BNT162b2 was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the event Drug Ineffective, Covid 19, skin disorder, pain in arm, arthralgia, back pain, neck pain to product and the suspect drug cannot be ruled out, hence the causality was kept as related. The case will be reassessed once new information is available.
Hands began itching, later led to anaphylaxis Itching, loss of consciousness, red, hives, difficulty breathing, face, hands, mouth, tongue, throat swollen, face and mouth numb, nausea, stomach distress, drop in blood pressure, increased heart rate, sweating
pt recvd vax MAR92 & 2 wks following vax pt devel arthralgias, arthritis & fever; DEC92 bone scan showed arthritis of acromium clavacular joint, bilaterally; C-reactive protein was sl elevated;
This spontaneous report as received from a nurse refers to an unspecified number of unspecified patients. No information on patient's pertinent medical history, drug reactions or allergies was provided. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # L040445, expiration date: 15-JAN-2017, dose and route of administration were not reported). The ZOSTAVAX was stored in temperature of -11C degrees for 2216 hours captured in Data Logger. There was no previous excursions. No adverse effects were reported. Additional information has been requested. This is a one of the several reports from the same reporter source.
Pt devel achiness in both arms shortly p/flu vax; subsequently devel intermittent cramps in both arms w/weakness in both arms & was unable to lift arms over head;
Patient said arm was sore with redness extending from 1" below injection site toward hand. Resolved by itself within a few days.